Lynn Arditi

Healthcare Reporter

Arditi joins RIPR after more than three decades as a reporter, including 28 years at the Providence Journal, where she has covered a variety of beats, most recently health care. A native of New York City, she graduated from Oberlin College with a degree in government and has worked as a staff writer for The Center for Investigative Reporting in Washington, D.C. and as a reporter for the former Holyoke Transcript-Telegram in Massachusetts.

Ways to Connect

RIPR FILE PHOTO

Are Americans ready to consider a single-payer health care system? What’s next for the Affordable Care Act, former President Barack Obama's signature health care law?

Rhode Island Public Radio’s health reporter Lynn Arditi and political analyst Scott MacKay sat down with Rhode Island’s U.S. Senator Sheldon Whitehouse to find out.

Elisabeth Harrison / RIPR

Rhode Island ranked third-highest in the country for the percentage of children with health insurance coverage, according to census data released Tuesday by Rhode Island KidsCount.

RIPR File Photo

Care New England's president and CEO, Dennis D. Keefe, announced Monday he will retire at the of the year as the hospital group prepares for a planned merger with Partners HealthCare of Massachusetts.

National Cancer Institute

Rhode Island’s immunization rates for teenagers are among the highest in the country, according to new data released by the U.S. Centers for Disease Control and Prevention.

Lynn Arditi / RIPR

Prescription opioids aren’t the only medication that public health officials worry about doctors over-prescribing. Another is antibiotics.


Ian Donnis / RIPR

U.S. Sen. Sheldon Whitehouse is raising alarms about a proposed sale of Care New England -- Rhode Island’s second-largest hospital group to a large out-of-state hospital chain.

Lifespan, Rhode Island’s largest hospital system, is reporting strong operating earnings as rival Care New England continues to lose money.

Lynn Arditi

Former Presidential Candidate Howard Dean predicts that Republicans are unlikely to stop the federal Medicaid reimbursements that help millions of low-income Americans pay for out-of-pocket medical costs.